Myelofibrosis: Part I - Understanding the disease

Myelofibrosis: Part I - Understanding the disease

Haematology
A badge with ribbon in color black Point(s): 1 | An analog clock in color black 25 minutes | A black calendar with white triangle in center that has a black exclamation point in the middle 07 May 2022 

Overview

NEW!


Myelofibrosis (MF) is a heterogeneous disorder with multiple characteristics dominated by the effects of progressive bone marrow fibrosis. The goal of this learning activity is to provide doctors with a review of MF.


Upon completing this module, participants will have a better understanding of its:

  Epidemiology and pathophysiology

  Clinical presentation

  Diagnosis and prognosis

  Path to referral


CPD reviewer:

Dr Haifa Kathrin Al-Ali, MD, PD

Associate Professor

Department of Haematology and Medical Oncology

University Hospital of Halle (Saale)

Germany

• Lecture

• Q&A session


Who should participate:

• Doctors


NOTE :

Please watch the video before attempting the assessment questions.


Terms & Conditions:

■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.

■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points


To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.


Sponsored by:

Novartis_logo.jpg